It’s Class I For Medtronic’s Valiant Navion Recall

The US FDA gave its highest risk classification to a recent recall of the Valiant Navion Thoracic Stent Graft System. Two serious injuries and one death – a clinical trial participant – were reported.

Sign of Medtronic at Canada Headquarters in Brampton, Ontario, Canada.

More from Recalls

More from Policy & Regulation